Geissinger E, Adam P, Müller-Hermelink H K, Rüdiger T
Institut für Pathologie, Universität Würzburg.
Pathologe. 2007 Feb;28(1):15-20. doi: 10.1007/s00292-006-0881-7.
Primary cutaneous B-cell lymphomas include cutaneous follicle centre lymphoma (PCFCL), cutaneous marginal zone B-cell lymphoma (PCMZL) and cutaneous diffuse large B-cell lymphoma (PCLBCL) "leg type" which are the three main types in the new WHO-EORTC classification for cutaneous lymphomas. PCFCL and PCMZL are indolent lymphomas with an excellent prognosis while PCLBCL shows an aggressive clinical course. All three types must be distinguished from a secondary skin involvement by systemic lymphomas. Since histological and immunohistochemical findings are not decisive, making this distinction requires appropriate staging procedures. In contrast, the pathologist can make an important contribution to the differential diagnosis between neoplastic and reactive cutaneous lymphoproliferations.
原发性皮肤B细胞淋巴瘤包括皮肤滤泡中心淋巴瘤(PCFCL)、皮肤边缘区B细胞淋巴瘤(PCMZL)和皮肤弥漫性大B细胞淋巴瘤(PCLBCL)“腿部型”,它们是世界卫生组织-欧洲肿瘤研究与治疗组织(WHO-EORTC)皮肤淋巴瘤新分类中的三种主要类型。PCFCL和PCMZL是惰性淋巴瘤,预后良好,而PCLBCL具有侵袭性临床病程。所有这三种类型都必须与系统性淋巴瘤继发的皮肤受累相鉴别。由于组织学和免疫组化结果并非决定性因素,进行这种鉴别需要适当的分期程序。相比之下,病理学家在肿瘤性和反应性皮肤淋巴细胞增生的鉴别诊断中可发挥重要作用。